Cargando…
Pharmacotherapy for mild hypertension
BACKGROUND: People with no previous cardiovascular events or cardiovascular disease represent a primary prevention population. The benefits and harms of treating mild hypertension in primary prevention patients are not known at present. This review examines the existing randomized controlled trial (...
Autores principales: | Diao, Diana, Wright, James M., Cundiff, David K., Gueyffier, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522316/ https://www.ncbi.nlm.nih.gov/pubmed/23338742 http://dx.doi.org/10.1590/S1516-31802012000600012 |
Ejemplares similares
-
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2015) -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2014) -
Vitamin D supplementation for women during pregnancy
por: De-Regil, Luz Maria, et al.
Publicado: (2015) -
Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
por: Liira, Juha, et al.
Publicado: (2014) -
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
por: Jefferson, Tom, et al.
Publicado: (2014)